Status:
UNKNOWN
Horizontal Augmentation With Deproteinized Bovine Bone Mineral Alone or in Combination With Particulate Autogenous Bone
Lead Sponsor:
NU-Hospital Organization, Sweden
Collaborating Sponsors:
Aalborg University Hospital
Conditions:
Edentulous Jaw
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: Placement of oral implants is frequently compromised due to atrophy of the alveolar process. Lateral ridge augmentation with an autogenous bone block is frequently necessary to increase th...
Eligibility Criteria
Inclusion
- Total or partial bilateral edentulism
- Horizontal bone width less than 4 mm at planned sites of implant installation or need of augmentation of aesthetic reasons for optimal implant placement
Exclusion
- Uncontrolled systematic disease
- History of radiation in the area
- Smoking habits (free of smoking habits more than 1 month prior to treatment)
- Treatment with bisphosphonates
- Patients who cannot complete the 5-year observation period
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04755166
Start Date
June 1 2016
End Date
December 31 2024
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NU Hospital Organization
Trollhättan, Sweden, 46273